Search Results

Search Results

topic

audience

Results returned for Thrombosisfrom all of CDC.gov
Blood Clots (Deep Vein Thrombosis). What to know. People who have cancer now or had cancer in the past have a higher risk of getting a blood clot in a vein, which is a serious health problem. What is deep vein thrombosisRead more
Top takeaway: Healthcare professionals should counsel travelers about risk factors for and how to avoid blood clots during long-distance travel. Introduction. Deep vein thrombosis (DVT) is a condition in which a blood clot develops…Read more
DVT and PE are serious but often preventable conditions. Overview. Venous thromboembolism (VTE) is a term referring to blood clots in the veins. VTE includes deep vein thrombosis (DVT) and pulmonary embolism (PE). DVT occurs…Read more
Venous Thromboembolism (Blood Clots). About. Learn about symptoms, risk factors, and treatment for deep vein thrombosis and pulmonary embolism. Learn More. May 15, 2024 Featured. Diagnosing. Learn how blood clots are diagnosed…Read more
CDC’s Division of Blood Disorders (DBD) is proud to offer its Public Health Webinar Series on Blood Disorders. The purpose of this series is to provide evidence-based information on new research, interventions, emerging issues of interest…Read more
Notable updates include 1) the addition of recommendations for persons with chronic kidney disease; 2) revisions to the recommendations for persons with certain characteristics or medical conditions (i.e., breastfeeding, postpartum,…Read more
Weigh the risks and benefits of placing a central venous device at a recommended site to reduce infectious complications against the risk for mechanical complications (e.g., pneumothorax, subclavian artery puncture, subclavian vein…Read more
We treated the right jugular vein thrombosis with enoxaparin. The patient underwent surgical debridement with facial nerve monitoring; we collected transmastoid biopsy samples and pus for microbiological analysis and inserted…Read more
The Advisory Committee on Immunization Practices concluded that the benefits of resuming Janssen COVID-19 vaccination among persons aged ≥18 years outweighed the risks and reaffirmed its interim recommendation under FDA’s Emergency…Read more

Please use the search area above.

Please use the search area above.